Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks.

den Uyl D, ter Wee M, Boers M, Kerstens P, Voskuyl A, Nurmohamed M, Raterman H, van Schaardenburg D, van Dillen N, Dijkmans B, Lems W.

Ann Rheum Dis. 2014 Jun;73(6):1071-8. doi: 10.1136/annrheumdis-2012-202818. Epub 2013 Apr 19.

2.

Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.

Ursum J, Bos WH, van Dillen N, Dijkmans BA, van Schaardenburg D.

Arthritis Res Ther. 2010;12(1):R8. doi: 10.1186/ar2907. Epub 2010 Jan 12.

3.

Ankylosing spondylitis: a risk factor for myocardial infarction?

Peters MJ, Visman I, Nielen MM, Van Dillen N, Verheij RA, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT.

Ann Rheum Dis. 2010 Mar;69(3):579-81. doi: 10.1136/ard.2009.110593. Epub 2009 Apr 28.

PMID:
19403516

Supplemental Content

Loading ...
Support Center